EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanomedicine Strategies in the Management of Inflammatory Bowel Disease and Colorectal Cancer

Asia Xiao Xuan Tan iD, Brandon Yen Chow Ong iD, Tarini Dinesh iD, Dinesh Kumar Srinivasan iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136465 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Asia Xiao Xuan Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Nanomedicine, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota has emerged as a key area of biomedical research due to its integral role in maintaining host health and its involvement in the pathogenesis of many systemic diseases. Growing evidence supports the notion that gut dysbiosis contributes significantly to diseases and their progression. An example would be inflammatory bowel disease (IBD), a group of conditions that cause inflammation and swelling of the digestive tract, with the principal types being ulcerative colitis (UC) and Crohn’s disease (CD). Another notable disease with significant association to gut dysbiosis would be colorectal cancer (CRC), a malignancy which typically begins as polyps in the colon or rectum, but has the potential to metastasise to other parts of the body, including the liver and lungs, among others. Concurrently, advances in nanomedicine, an evolving field that applies nanotechnology for disease prevention, diagnosis, and treatment, have opened new avenues for targeted and efficient therapeutic strategies. In this paper, we provide an overview of the gut microbiota and the implications of its dysregulation in human disease. We then review the emerging nanotechnology-based approaches for both therapeutic and diagnostic purposes, with a particular focus on their applications in IBD and CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNanomedicineInflammatory Bowel DiseasesHumansGastrointestinal MicrobiomeAnimalsDysbiosis

Stichwörter der Autor:innen

colorectal cancerdrug delivery systemsgut dysbiosisinflammatory bowel diseasenanodiagnosticsnanomedicinenanotherapeutics

Autor:innen und Institutionen

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
  • Department of Anaesthesia, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore.
  • Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore.

ORCID-Profile: Asia Xiao Xuan Tan, Brandon Yen Chow Ong, Tarini Dinesh, Dinesh Kumar Srinivasan

Zitieren

APA

Tan, A. X. X., Ong, B. Y. C., Dinesh, T., & Srinivasan, D. K. (2025). Nanomedicine Strategies in the Management of Inflammatory Bowel Disease and Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136465

Vancouver

Tan AXX, Ong BYC, Dinesh T, Srinivasan DK. Nanomedicine Strategies in the Management of Inflammatory Bowel Disease and Colorectal Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136465

BibTeX
@article{Tan2025,
  author = {Tan, Asia Xiao Xuan and Ong, Brandon Yen Chow and Dinesh, Tarini and Srinivasan, Dinesh Kumar},
  title = {Nanomedicine Strategies in the Management of Inflammatory Bowel Disease and Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136465}
}
Kostenlos starten →